Erratum: Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat (British Journal of Pharmacology (2004) 143 (697-704) doi:10.1038/sj.bjp.0705966);Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat

British Journal of Pharmacology

Volumn 143, Issue 6, 2004, Pages 697-704

  Petersen, Kenneth A ^a   Birk, Steffen ^a   Doods, Henri ^b   Edvinsson, Lars ^c   Olesen, Jes ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

BIBN4096BS; CGRP and CGRP receptor antagonism; Cortical pial arterioles and cortical cerebral blood flow; Middle meningeal artery; Migraine

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; ANTIMIGRAINE AGENT; BETA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; N [2 [[5 AMINO 1 [(4 PYRIDINYL) 1 PIPERAZINYL]CARBONYL]PENTYL]AMINO] 1 (3,5 DIBROMO 4 HYDROXYPHENYL)METHYL 2 OXOETHYL 4 (1,4 DIHYDRO 2 OXO 3(2H) QUINAZOLINYL) 1 PIPERIDINECARBOXAMIDE; OLCEGEPANT; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; ARTIFICIAL VENTILATION; BRAIN BLOOD FLOW; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSTIMULATION; HYPOTENSION; MALE; MENINGEAL ARTERY; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 10044259901     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706080     Document Type: Erratum

References (40)

1. AIYAR, N., DAINES, R.A., DISA, J., CHAMBERS, P.A., SAUERMELCH, C.F., QUINIOU, M., KHANDOUDI, N., GOUT, B., DOUGLAS, S.A. & WILLETTE, R.N. (2001). Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J. Pharmacol. Exp. Ther., 296, 768-775.
2. AKERMAN, S., WILLIAMSON, D.J., KAUBE, H. & GOADSBY, P.J. (2002). Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br. J. Pharmacol., 137, 62-68.
3. BASKAYA, M.K., SUZUKI, Y., ANZAI, M., SEKI, Y., SAITO, K., TAKAYASU, M., SHIBUYA, M. & SUGITA, K. (1995). Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs. J. Cereb. Blood Flow Metab., 15, 827-834.
4. BEATTIE, D.T., MCNEIL, D.K. & CONNOR, H.E. (1993). The influence of neurokinins and calcitonin gene-related peptide on cerebral blood flow in anaesthetized guinea-pigs. Neuropeptides, 24, 343-349.
5. DOODS, H., HALLERMAYER, G., DONGMEI, W., ENTZEROT, M., RUDOLF, K., ENGEL, W. & EBERLEIN, W. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol., 129, 420-423.
6. EDVINSSON, L., ALM, R., SHAW, D., RUTLEDGE, R.Z., KOBLAN, K.S., LONGMORE, J. & KANE, S.A. (2002). Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur. J. Pharmacol., 434, 49-53.
7. EDVINSSON, L., ELSAS, T., SUZUKI, N., SHIMIZU, T. & LEE, T.J. (2001a). Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. Microsc. Res. Tech., 53, 221-228.
8. EDVINSSON, L., SAMS, A., JANSEN-OLESEN, I., TAJTI, J., KANE, S.A., RUTLEDGE, R.Z., KOBLAN, K.S., HILL, R.G. & LONGMORE, J. (2001b). Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur. J. Pharmacol., 415, 39-44.
9. FARACI, P.M., KADEL, K.A. & HEISTAD, D.D. (1989). Vascular responses of dura mater. Am. J. Physiol., 257, H157-H161.
10. FOULKES, R., SHAW, N., BOSE, C. & HUGHES, B. (1991). Differential vasodilator profile of calcitonin gene-related peptide in porcine large and small diameter coronary artery rings. Eur. J. Pharmacol., 201, 143-149.
11. GERRITS, R.J., STElN, E.A. & GREENE, A.S. (1998). Laser-Doppler flowmetry utilizing a thinned skull cranial window preparation and automated stimulation. Brain Res. Brain Res. Protoc., 3, 14-21.
12. GOADSBY, P.J. & EDVINSSON, L. (1994). Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain, 117, 427-434.
13. GOADSBY, P.J., EDVINSSON, L. & EKMAN, R. (1988). Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann. Neurol., 23, 193-196.
14. Goadsby, P.J., EDVINSSON, L. & EKMAN, R. (1990). Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol., 28, 183-187.
15. GOADSBY, P.J., ZAGAMI, A.S. & LAMBERT, G.A. (1991). Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache, 31, 365-371.
16. GULBENKIAN, S., UDDMAN, R. & EDVINSSON, L. (2001). Neuronal messengers in the human cerebral circulation. Peptides, 22, 995-1007.
17. HARPER, S.L., BOHLEN, H.G. & RUBIN, M.J. (1984). Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am. J. Physiol., 246, H17-H24.
18. HONEY, A.C., BLAND-WARD, P.A., CONNOR, H.E., FENIUK, W. & HUMPHREY, P.P. (2002). Study of an adenosine A1 receptor agonist on trigeminally evoked durai blood vessel dilation in the anaesthetized rat. Cephalalgia, 22, 260-264.
19. HONG, K.W., PYO, K.M., LEE, W.S., YU, S.S. & RHIM, B.Y. (1994). Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation. Am. J. Physiol., 266, H11-H16.
20. JANSEN-OLESEN, I., JORGENSEN, L., ENGEL, U. & EDVINSSON, L. (2003). In-depth characterization of CGRP receptors in human intracranial arteries. Eur. J. Pharmacol., 481, 207-216.
21. KNUDSEN, G., JUHLER, M. & PAULSEN, O. (1988). Morphology, physiology and pathophysiology of the blood brain barrier. In: Basic Mechanisms of Migraine, ed. Olesen, J. & Edvinsson, L. pp. 49-60. Amsterdam: Elsevier Science Publisher.
22. KONTOS, H.A., WEI, E.P., NAVARI, R.M., LEVASSEUR, J.E., ROSENBLUM, W.I. & PATTERSON JR, J.L. (1978). Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am. J. Physiol., 234, H371-H383.
23. KUROSAWA, M., MESSLINGER, K., PAWLAK, M. & SCHMIDT, R.F. (1995). Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br. J. Pharmacol., 114, 1397-1402.
24. LASSEN, L.H., HADERSLEV, P.A., JACOBSEN, V.B., IVERSEN, H.K., SPERLING, B. & OLESEN, J. (2002). CGRP may play a causative role in migraine. Cephalalgia, 22, 54-61.
25. MARKOWITZ, S., SAITO, K. & MOSKOWITZ, M.A. (1988). Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia, 8, 83-91.
26. MCCULLOCH, J., UDDMAN, R., KINGMAN, T.A. & EDVINSSON, L. (1986). Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc. Natl. Acad. Sci. U.S.A., 83, 5731-5735.
27. MORENO, M.J., TERRON, J.A., STANIMIROVIC, D.B., DOODS, H. & HAMEL, E. (2002). Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture. Neuropharmacology, 42, 270-280.
28. OLESEN, J., DIENER, H.C., HUSSTEDT, I.W., GOADSBY, P.J., HALL, D., MEIER, U., POLLENTIER, S. & LESKO, L.M. (2004). Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med., 350, 1104-1110.
29. OLIVER, K.R., WAINWRIGHT, A., EDVINSSON, L., PICKARD, J.D. & HILL, R.G. (2002). Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J. Cereb. Blood Flow Metab., 22, 620-629.
30. PETERSEN, K., LASSEN, L.H., BIRK, S. & OLESEN, J. (2003). The effect of the CGRP-antagonist, BIBN4096BS on human-alpha CGRP induced headache and hemodynamics in healthy volunteers. Cephalalgia, 23, 725.
31. PETERSEN, K., DYRBY, L., WILLIAMSON, D.J., EDVINSSON, L. & OLESEN, J. (2004a). Effect of hypotension and carbon dioxide changes in an improved genuine closed cranial window rat model. Cephalalgia, in press.
32. PETERSEN, K., NILSSON, E., OLESEN, J. & EDVINSSON, L. (2004b). Presence and function of the CGRP receptor on rat pial arteries investigated in vitro and in vivo. Cephalalgia, in press.
33. SCHINDLER, M. & DOODS, H.N. (2002). Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand. [(3)H]BIBN4096BS. Eur. J. Pharmacol., 442, 187-193.
34. SUZUKI, Y., SATOH, S., IKEGAKI, I., OKADA, T., SHIBUYA, M., SUGITA, K. & ASANO, T. (1989). Effects of neuropeptide Y and calcitonin gene-related peptide on local cerebral blood flow in rat striatum. J. Cereb. Blood Flow Metab., 9, 268-270.
35. WEI, E.P., MOSKOWITZ, M.A., BOCCALINI, P. & KONTOS, H.A. (1992). Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ. Res., 70, 1313-1319.
36. WILLIAMSON, D.J., HARGREAVES, R.J., HILL, R.G. & SHEPHEARD, S.L. (1997a). Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia, 17, 518-524.
37. WILLIAMSON, D.J., HARGREAVES, R.J., HILL, R.G. & SHEPHEARD, S.L. (1997b). Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat - intravital microscope studies. Cephalalgia, 17, 525-531.
38. WU, D. (1999). Pharmacological characterization of calcitonin gene-related peptide receptors and BIBN4096BS - a novel CGRP receptor antagonist. The Netherlands: Doctural, University of Amsterdam.
39. WU, D., EBERLEIN, W., RUDOLF, K., ENGEL, W., HALLERMAYER, G. & DOODS, H. (2000). Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor. Eur. J. Pharmacol., 400, 313-319.
40. ZAGAMI, A.S., GOADSBY, P.J. & EDVINSSON, L. (1990). Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides, 16, 69-75.